HomeCOYA • NASDAQ
add
Coya Therapeutics Inc
Previous close
$6.08
Day range
$6.13 - $6.74
Year range
$4.75 - $10.68
Market cap
108.60M USD
Avg Volume
125.07K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.23M | 12.91% |
Net income | -4.02M | -17.52% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.44M | -24.91% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.06M | 185.29% |
Total assets | 35.55M | 198.87% |
Total liabilities | 3.54M | 96.04% |
Total equity | 32.01M | — |
Shares outstanding | 16.71M | — |
Price to book | 2.90 | — |
Return on assets | -29.48% | — |
Return on capital | -33.08% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -4.02M | -17.52% |
Cash from operations | -5.46M | -146.44% |
Cash from investing | 0.00 | — |
Cash from financing | -56.33K | — |
Net change in cash | -5.52M | -148.98% |
Free cash flow | -4.64M | -354.51% |
About
Founded
2020
Headquarters
Website
Employees
8
